EP 0524211 B1 19950308 - PHARMACEUTICAL FORMULATION.
Title (en)
PHARMACEUTICAL FORMULATION.
Title (de)
ARZNEIMITTEL.
Title (fr)
FORMULATION PHARMACEUTIQUE.
Publication
Application
Priority
- GB 9100516 W 19910402
- GB 9007945 A 19900407
Abstract (en)
[origin: WO9115197A1] A pharmaceutical formulation comprising an amoxycillin hydrate and an effervescent couple, for example citric acid plus sodium bicarbonate or sodium glycine carbonate, or tartaric acid or malic plus sodium carbonate. Potassium equivalents of these sodium salts may be used. The formulations may be free flowing powders or granules, or tablets.
IPC 1-7
IPC 8 full level
A61K 9/46 (2006.01); A61K 31/43 (2006.01)
CPC (source: EP)
A61K 9/0007 (2013.01); A61K 31/43 (2013.01)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9115197 A1 19911017; AT E119390 T1 19950315; AU 7558691 A 19911030; CA 2079904 A1 19911008; DE 69108022 D1 19950413; DE 69108022 T2 19950720; DE 69108022 T3 20000420; EP 0524211 A1 19930127; EP 0524211 B1 19950308; EP 0524211 B2 19990811; GB 9007945 D0 19900606; IE 911148 A1 19911009; JP 3234946 B2 20011204; JP H05505193 A 19930805; NZ 237710 A 19930526; PT 97264 A 19920131; ZA 912538 B 19920429
DOCDB simple family (application)
GB 9100516 W 19910402; AT 91907023 T 19910402; AU 7558691 A 19910402; CA 2079904 A 19910402; DE 69108022 T 19910402; EP 91907023 A 19910402; GB 9007945 A 19900407; IE 114891 A 19910405; JP 50651391 A 19910402; NZ 23771091 A 19910405; PT 9726491 A 19910405; ZA 912538 A 19910405